Search Results for Fair Balance

Showing 1 – 5

FDA Officials Study Alternative Approach to Presenting Risk Info in TV Drug Ads By Michael Mezher - Published 07 August 2017

A recent study by US Food and Drug Administration (FDA) officials and research firm RTI International suggests that an alternative approach to presenting limited risk information in direct-to-consumer (DTC) TV drug advertising may improve consumers' ability to recall those risks.

Categories: News, US, FDA, Advertising and Promotion, Drugs

Tags: Direct-to-Consumer, DTC, Drug Advertising, Risk, Fair Balance

FDA Considers Allowing Drug Companies to Drop Some Warnings in TV Commercials By Alexander Gaffney, RAC - Published 12 January 2015

The US Food and Drug Administration (FDA) has announced its plans to study whether consumers would benefit if direct-to-consumer television advertising contained a shorter list of major side effects instead of the now-lengthy list of nearly all of them.

Categories: News, US, CDER, Advertising and Promotion, Biologics and biotechnology, Drugs

Tags: DTC, DTC Advertising, Drug Risks, Fair Balance, Direct-to-Consumer, Study

OPDP Releases Third Untitled Letter in as Many Weeks By Alexander Gaffney, RF News Editor - Published 14 November 2013

Categories: US, FDA

Tags: OPDP, Untitled Letter, APL, fair balance

J&J's Janssen Gets Second Untitled Letter in as Many Months as FDA Targets Xarelto Advertising Piece By Alexander Gaffney, RF News Editor - Published 19 June 2013

Categories: US, FDA

Tags: Untitled Letter, Janssen, J&J, Xarelto, Johnson & Johnson, Latest News, fair balance

Study: OTC Drug Advertising Lacks Sufficient Balance of Risks, Benefits By Alexander Gaffney - Published 12 September 2012

Categories: FDA, FTC

Tags: JAMA, OTC, Latest News, pharmaceutical, marketing, advertising, study, fair balance, drug